alanylglutamic acid has been researched along with Dengue in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fürst, P; Klassen, P; Mazariegos, M; Solomons, NW | 1 |
1 other study(ies) available for alanylglutamic acid and Dengue
| Article | Year |
|---|---|
The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute Dengue fever.
Topics: Administration, Oral; Adolescent; Adult; Alanine; Anti-Ulcer Agents; Area Under Curve; Case-Control Studies; Chromatography, High Pressure Liquid; Dengue; Dipeptides; Drug Administration Schedule; Gastric Acid; Gastric Mucosa; Glutamine; Guatemala; Half-Life; Humans; Hydrogen-Ion Concentration; Middle Aged; Omeprazole | 2000 |